Author

Mikael Holm

ORCID 0000-0002-4361-9554Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anthony P. SchulleriD· 1 shared Canessa J. Swanson-Swett· 1 shared David Gygi· 1 shared Grant W. Wienker· 1 shared Hailey K. Adams· 1 shared Justin Seiwert Sim· 1 shared Lawrence G. HamanniD· 1 shared Lillian Kenner· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anthony P. SchullerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Context-dependent translation inhibition as a novel oncology therapeutic modality

Paige D. Diamond, Paul Victor Sauer, Mikael Holm, Canessa J. Swanson-Swett, Lucas Ferguson, Natalie M. Bratset, Grant W. Wienker, Justin Seiwert Sim, Hailey K. Adams, Lillian Kenner, Margot Meyers, David Gygi, Zef A. Könst, Sogole Sami Bahmanyar, Lawrence G. Hamann, Anthony P. Schuller

This paper develops interdictors that selectively inhibit translation elongation in the human ribosome, showing their efficacy in tumor growth inhibition in a breast cancer model.

bioRxiv · Jan 9, 2025 · PreprintCancer Biology